Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
GLOBETECH PUBLISHING LLC
Schiller

Dilon Acquires Navigator Gamma Probe Company

By Medimaging International staff writers
Posted on 13 Jan 2014
Dilon Technologies, Inc. (Newport News, VA, USA) has acquired the assets of the Navigator gamma probe business from RMD Instruments Corp. (Watertown, MA, USA), a subsidiary of Dynasil Corporation of America.

RMD Instruments manufactures and sells a range of intraoperative surgical probes that are distributed both in the United States and worldwide. The acquired products are used in surgery for procedures such as pulmonary wedge resection and sentinel lymph node biopsy. The company recently introduced its Navigator 2.0 wireless probe, which has been very well received by the market place.

“In addition to our market leadership in the small field-of-view molecular breast imaging market, this acquisition is consistent with our objective of expanding our product offering in both the diagnostic and surgical segments of the market and comes on the heels of our recent agreement with Digirad [Suwanee, GA, USA],” commented Robert G. Moussa, Dilon’s CEO.

“We are pleased to have found a wonderful home for our Navigator Probe technology, one of the most widely used gamma probes for cancer surgery in the marketplace. Dilon Technologies is well situated to expand the gamma probe market and we look forward to working with them over the coming months to transition the product from our manufacturing facility to Dilon,” commented Peter Sulick, Dynasil’s chairman and interim CEO.

Dynasil, for the time being, will continue to manufacture and distribute the products, maintaining continuity in supply and regulatory compliance.

Dilon Technologies’ keystone product, the Dilon molecular imaging system (MBI), is a high-resolution, small field-of-view digital gamma camera, optimized for MBI/breast-specific gamma imaging (BSGI). MBI utilizes radiotracer uptake to detect the increased metabolic activity of breast lesions and therefore, is not affected by breast density. Both the Dilon 6800 and Acella systems provide high photon sensitivity; and Dilon’s GammaLoc system is the only localization device on the market to enable molecular-guided breast biopsy.

Digirad is one of the largest US providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers, and also sells medical diagnostic imaging systems for nuclear cardiology and general nuclear medicine applications.

Related Links:

Dilon Technologies
RMD Instruments
Digirad



Channels

Radiography

view channel

Results of a Study into the Use of Low-Tube-Voltage for CT Colonography Published

Researchers from the Department of Diagnostic Radiology, at the Kumamoto University (Kumamoto, Japan) investigating the effect of a low-tube voltage technique and iterative reconstruction on the image quality and radiation dose of Computed Tomography Colonography (CTC), have been published in the April 11, 2015, online... Read more

MRI

view channel
Image: The ViewRay MRIdian System (Photo courtesy of ViewRay).

Unique MRI-Guided Radiation Therapy System Showcased at ESTRO 2015

ViewRay (Cleveland OH, USA) has demonstrated their advanced radiation therapy technology for the treatment of cancer at the April, 2015, European Society for Therapeutic Radiology and Oncology (ESTRO)... Read more

Ultrasound

view channel

Ultrasound Device Reduces the Number of Tests Required for Inpatients and Outpatients

The results of a study carried out by the European Association for the Study of the Liver (EASL; Geneva, Switzerland) into the use of a Pocket-sized Ultrasound Device (PUD) together with a physical examination, have been presented at the 2015 International Liver Congress, in Vienna (Austria). The study evaluated the... Read more

Nuclear medicine

view channel
Image: PET scan images (Courtesy of King’s College London).

Preventing Unnecessary Radiotherapy for Patients with Early-Stage Hodgkin’s Lymphoma

A new study suggested that patients with early-stage (stage 1a or 2a) Hodgkin’s lymphoma disease, who underwent three cycles of chemotherapy with the drugs doxorubicin, bleomycin, vinblastine, and dacarbazine... Read more

General/Advanced Imaging

view channel

Global Healthcare Study of Coronary Artery Disease Reaches Significant Milestone

A major milestone has been reached in the Lipid-Rich Plaque (LRP) study, a prospective, multicenter clinical trial with the potential to reveal breakthrough correlations between Lipid-Rich Plaques and occurrence of heart attacks. The LPR study has now enrolled 1,000 patients, and aims to identify a correlation between... Read more

Imaging IT

view channel
Image: Clinical Collaboration Platform (Photo courtesy of Carestream Healthcare).

New, Advanced Medical Imaging and Healthcare IT Products Showcased in HIT Expo in Paris

A medical imaging systems and Information Technology (IT) solutions provider has demonstrated its advanced imaging IT platform and product updates at Health-IT (HIT) Expo 2015 on May 19–21, in Paris (France).... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.